Zion Biotech Co., Ltd.

Zion Biotech Co., Ltd. is a medical equipment manufacturer with the core business of designing/developing/manufacturing proton cancer treatment equipment based on "clinical experience" innovation. Founded in 2010, Zion Biotech founder and CEO Chen Jin-an introduced the proton therapy clinical experience of the Proton Therapy Center of Massachusetts General Hospital, Harvard Medical School in the United States, and innovated industry-university-research cooperation methods to integrate international cancer proton equipment technology teams with related technologies. Zion Biotech uses a synchrotron as the core of the proton therapy machine, and adopts AI digitalization, high reliability, and excellent performance solid-state high-frequency electromagnetic wave transmitter, and digital power supply system to provide high stability and low noise magnet power supply, thereby ensuring the stability of the proton beam orbit. At the same time, it introduces the clinical needs of cancer medical treatment, and uses a variable energy synchrotron (70 - 250 MeV), combined with three-dimensional scanning treatment technology (IMPT), six-axis spatial positioning system (Z-Robot couch), and real-time image processing (in room CT/CBCT) to provide advanced proton targeted cancer treatment technology. Zion Company adheres to the tenet of Taiwan R&D and global marketing. The company's product planning integrates Taiwan's and international advanced technologies to provide high-quality proton equipment with reasonable prices, which is expected to reduce the construction cost of proton therapy equipment and rationalize patient treatment costs, benefiting more cancer patients.